LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals (AMEX: BPA) today reported its September 30, 2006 cash balance and its financial results for the third quarter and nine months ended September 30, 2006. In addition, BioSante reviewed its recently signed marketing agreement with Bradley Pharmaceuticals, Inc. (NYSE: BDY).
